Chembio Diagnostics receives FDA approval for DPP HIV-syphilis system

Chembio Diagnostics

2 October 2020 - Chembio Diagnostics today announced that the U.S. FDA has approved the premarket approval application for the DPP HIV-Syphilis System. 

The system includes the DPP HIV-Syphilis assay, a multiplex single-use test, and the DPP Micro Reader optical analyser, and is being offered in the United States immediately.

Read Chembio Diagnostics press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , US , Diagnostic agent